학술논문

Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)
Document Type
Short Communication
Source
In Journal of Thoracic Oncology February 2021 16(2):327-333
Subject
Language
ISSN
1556-0864